Showing results 1 to 5 of 5
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Comparing self-reported reactogenicity between adolescents and adults following the use of BNT162b2 (Pfizer-BioNTech) messenger RNA Covid-19 vaccine: a prospective cohort study Journal:International Journal of Infectious Diseases | 2022 | ||
| 2011 | |||
Risk of Adverse Events and Delirium after COVID-19 Vaccination in Patients Living with Dementia Journal:Journal of the American Medical Directors Association | 20-Apr-2023 | ||
Risk of carditis after three doses of vaccination with mRNA (BNT162b2) or inactivated (CoronaVac) covid-19 vaccination: a self-controlled cases series and a case–control study Journal:The Lancet Regional Health - Western Pacific | 1-Jul-2023 | ||
Safety of BNT162b2 or CoronaVac COVID-19 vaccines in patients with heart failure: a self-controlled case series study Journal:The Lancet Regional Health - Western Pacific | 7-Nov-2022 |